5-Hydroxytryptamine (serotonin) receptor 5A, also known as HTR5A, is a protein that in humans is encoded by the HTR5A gene. Agonists and antagonistss for 5-HT receptors, as well as serotonin uptake inhibitors, present promnesic (memory-promoting) and/or anti-amnesic effects under different conditions, and 5-HT receptors are also associated with neural changes.

Function

The gene described in this record is a member of 5-hydroxytryptamine receptor family and encodes a multi-pass membrane protein that functions as a receptor for 5-hydroxytryptamine and couples to G proteins, negatively influencing cAMP levels via Gi and Go. This protein has been shown to function in part through the regulation of intracellular Ca2+ mobilization. The 5-HT5A receptor has been shown to be functional in a native expression system.

Rodents have been shown to possess two functional 5-HT5 receptor subtypes, 5-HT5A and 5-HT5B, however while humans possess a gene coding for the 5-HT5B subtype, its coding sequence is interrupted by stop codons, making the gene non-functional, and so only the 5-HT5A subtype is expressed in human brain.

It also appears to serve as a presynaptic serotonin autoreceptor.

Clinical significance

The neurotransmitter serotonin (5-hydroxytryptamine, 5-HT) has been implicated in a wide range of psychiatric conditions and also has vasoconstrictive and vasodilatory effects.

Selective ligands

Few highly selective ligands are commercially available for the 5-HT5A receptor, though the field has expanded considerably in recent years. When selective activation of this receptor is desired in scientific research, the non-selective serotonin receptor agonist 5-Carboxamidotryptamine can be used in conjunction with selective antagonists for its other targets (principally 5-HT1A, 5-HT1B, 5-HT1D, and 5-HT7). Research in this area is ongoing.

Agonists

• LSD:(+)-lysergic acid.

• Lisuride partial agonist.

• 5-CT full agonist.

• Methylergometrine full agonist.

• Valerenic acid a component of valerian, has been shown to act as a 5HT5A partial agonist.

• Olanzapine an atypical antipsychotic.

• Psilocin

• Aripiprazole - an atypical antipsychotic

• Mirtazapine - an atypical antidepressant

• UCSF648 - selective 5-HT5A partial agonist

• Another ligand that has been recently disclosed is shown below, claimed be a selective 5-HT5A agonist with Ki = 124 nM.

Antagonists

• ASP5736

• AS-2030680

• AS-2674723

• MS112 selective potent antangonist.

• Latrepirdine (non-selective).

• Risperidone (non-selective), moderate 206nM affinity.

• SB-699,551

See also

• 5-HT receptor

• 5-HT1 receptor

• 5-HT2 receptor

• 5-HT3 receptor

• 5-HT4 receptor

• 5-HT6 receptor

• 5-HT7 receptor

References

Further reading

External links